Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

More FDA Oversight Of DTC Ads May Be Needed To Curtail Misleading Claims, Study Argues

Mar 07 2018

• By Jessica Merrill

Related Content

Rx Promotion Citations By US FDA Plummet; UCLA Webpage Elicits Final Letter Of 2017

Jan 24 2018

Diabetes DTC Ads Stand Out For Off-Label Promotion, Study Finds

Mar 05 2018

DTC Trouble: ‘Attention-Grabbing Visuals’ Undermine Risk Info, FDA Tells Celgene, Sanofi

Dec 15 2016

Related Companies

CSL Limited

Novo Nordisk A/S

Johnson & Johnson

AstraZeneca PLC

Eli Lilly and Company

Additional Topics

United States Advertising, Marketing & Sales Regulation Metabolic Disorders BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window